Login
Join free
Add to favorites
中文
Home
|
Suppliers
|
Products
|
News
|
Events and Expos
|
About Us
Products
Products
Suppliers
News
Events/Expos
Let suppliers know what you want to buy!
Home
Suppliers
Products
News
New Products
Supplier News
Upcoming Events
Business
Web
Events and Expos
About Us
Products
Products
Suppliers
News
Events
home
> Search results for
illumina
in News
Search results for
illumina
in News
Expression Analysis Certified on Illumina Platforms
2/20/2010
2195
Hits
DNAVision Adds Illumina HiSeq to Service Offerings
2/9/2010
2423
Hits
Illumina, Cepheid Top Gainers in Down Month for GWDN Index
2/3/2010
238 Hits
Illumina Debuts New BeadChips to Meet 'Continued Interest'...
1/15/2010
2428
Hits
Illumina Focuses on New Sequencer, Array Products
1/13/2010
2625
Hits
Illumina Files Patent Infringement Suit Against Affymetrix
11/10/2009
1887
Hits
Illumina Sells 30 More Genome Analyzers to Broad Institute
11/6/2009
1992
Hits
Illumina, Agilent Technologies to Co-Market Targeted Resequencing Solu...
4/22/2009
2555
Hits
Eppendorf Multipette with illuminated display
8/7/2007
5048
Hits
Neuroscience Microarray Consortium Installs Affy and Illumina Array...
3/30/2007
2706
Hits
Illumina Licenses Oxford Gene Techs DNA Sequence Variation Patents
12/21/2006
213 Hits
<
1
2
3
>
Related news
1.
Tahoe Therapeutics generates the largest single-cell atlas ever using INTEGRA Biosciences automated pipetting technologies
2.
Evaluating the Clinical Value of Chromogranin A Antibodies in Neuroendocrine Tumor Diagnosis and Treatment
3.
CPHI & PMEC China 2026: Revolutionizing Laboratory Innovation in Asia
4.
Unveiling the Multifaceted Value of CGA/HCG-α: From Pregnancy Monitoring to Disease Diagnosis
5.
2026 World Radiology and Medical Imaging Conference (2026WRMI)
6.
Azenta Life Sciences and Frontier Space Announce Strategic Partnership
7.
Elucidating CD8α’s Core Mechanisms: Maintaining T Cell Homeostasis and Regulating Apoptosis
8.
Pharma Partnering EU Summit 2026
9.
Pharma Partnering US Summit 2026
10.
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
advertisement